IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pathway Capital Management, LP

Q3 2025 Holdings

Filed 2025-11-04 | 7 holdings | $20.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$6.8M119,27933.3%
Arcellx, Inc.(ACLX)COMMON STOCK03940C100$4.2M51,05120.6%
Goodrx Holdings, Inc.(GDRX)COM CL A38246G108$4.2M986,15820.5%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$3.2M50,04915.9%
PDD Holdings Inc.(PDD)SPONSORED ADS722304102$951.2K7,1974.7%
NU Holdings Ltd.(NU)ORD SHS CL AG6683N103$944.8K59,0104.6%
Neuehealth IncCOM NEW10920V404$74.7K11,2010.4%